A step toward a universal flu vaccine
With computer models and lab experiments, researchers are working on a strategy for vaccines that could protect against any influenza virus.
Industry and scientific leaders examine Covid-19-era inequities, emphasize rapid testing
At MIT Forefront, panelists discuss health care and work during a pandemic — and the role for business where government falls short.
Syringe technology could enable injection of concentrated biologic drugs
Researchers have designed a simple, low-cost device for subcutaneous injection of viscous formulations.
SMART research enhances dengue vaccination in mice
Sequential immunization might be safer and more effective than the existing tetravalent vaccine.
Rapid antibody development yields possible treatment for yellow fever
The experimental drug has shown promise in early-stage clinical trials conducted in Singapore.
Engineers use “DNA origami” to identify vaccine design rules
In lab tests, virus-like DNA structures coated with viral proteins provoke a strong immune response in human B cells.
Improving global health equity by helping clinics do more with less
The startup macro-eyes uses artificial intelligence to improve vaccine delivery and patient scheduling.
How often do vaccine trials hit paydirt?
Study: Vaccines find more success in development than any other kind of drug, but have been relatively neglected in recent decades.
MIT’s Love Lab developing a Covid-19 vaccine to potentially reach billions
Manufacturability is key to producing a widely available, affordable vaccine.
MIT-affiliated companies take on Covid-19
A variety of companies with MIT ties are working to address aspects of the Covid-19 pandemic.
Storing medical information below the skin’s surface
Specialized invisible dye, delivered along with a vaccine, could enable “on-patient” storage of vaccination history to save lives in regions where paper or digital records aren’t available.
MIT Medical shatters previous one-day flu-shot record
During the community flu clinic on Oct. 3, at least 9,378 people on campus had received vaccinations — an average of one shot every 3.8 seconds.
Delivery system can make RNA vaccines more powerful
Vaccines packaged in novel nanoparticles could offer a new way to fight cancer and infectious diseases.
Structure of T cell epitopes a decisive factor in natural HIV control, study finds
Researchers apply network theory to HIV protein structure, uncovering a vital link between connectivity and protective immune response.
Squeezing cells to cure diseases
Startup SQZ Biotech aims to open a new path in immunotherapy with its cell-compressing technique.